- C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside.
- Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.
- A Gain-of-Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype.
- Oxytocin Prevents the Development of 3-NP-Induced Anxiety and Depression in Male and Female Rats: Possible Interaction of OXTR and mGluR2.
- Electroacupuncture Improves Motor Symptoms of Parkinson's Disease and Promotes Neuronal Autophagy Activity in Mouse Brain.
- Clinical Approach to Personality Change Due to Another Medical Condition.
- The Interaction of Aging and Cellular Stress Contributes to Pathogenesis in Mouse and Human Huntington Disease Neurons.
- A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities.
- GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington's Disease-Related Phenotypes.
- The role of Nrf2 in Neural stem/Progenitors cells: from maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease.
- Gene Expression Profiling in Huntington's Disease: Does Comorbidity with Depressive Symptoms Matter?
- Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders.
- Signaling by cGAS-STING in Neurodegeneration, Neuroinflammation, and Aging.
- Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.
- Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D1R Radioligand [11C]SCH23390 in Healthy and Diseased Mice.
- Morphine produces better thermal analgesia in young Huntington mice and are associated with less neuroinflammation in spinal cord.
- Hypermanganesemia Induced Chorea and Cognitive Decline in a Tea Seller.
- Emerging potential of cannabidiol in reversing proteinopathies.
- Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies.
- Cell therapy in Huntington's disease: taking stock of past studies to move the field forward.
- THE PHARMACOLOGICAL CASE FOR CANNABIGEROL (CBG).
- Expanding the arsenal against Huntington's disease- Herbal drugs and their nanoformulations.
- PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.
- Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.
- Molecular Mechanisms Underlying Muscle Wasting in Huntington's Disease.
- FOXO3 targets are reprogrammed as Huntington's disease neural cells and striatal neurons face senescence with p16INK4a increase.
- Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington's disease.
- Expanded CAG Repeats in ATXN1, ATXN2, ATXN3, and HTT in the 1000 Genomes Project.
- Advances in nanomedicines for diagnosis of central nervous system disorders.
- Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system.
- Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases.
- [Myelinosomes: A new pathway of protein quality control].
- Quantitative neurotoxicology: Potential role of artificial intelligence/deep learning approach.
- Corrigendum to "The impact of bilingualism on brain structure and function in Huntington's disease" [Park. Relat. Disord. 60C (3783) (2019) 92-97].
- Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases.
- Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report.
- Genome-wide DNA methylation analysis of cognitive function in middle and old-aged Chinese monozygotic twins.
- Selective Autophagy Receptors in Neuronal Health and Disease.
- Miro (Mitochondrial Rho GTPase), a key player of Mitochondrial axonal transport and Mitochondrial dynamics in Neurodegenerative diseases.
- Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases.
- Epigenetic mechanisms underlying enhancer modulation of neuronal identity, neuronal activity and neurodegeneration.
- Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease.
- P2X7 Receptor Upregulation in Huntington's Disease Brains.
- The Therapeutic Prospects of Naturally Occurring and Synthetic Indole Alkaloids for Depression and Anxiety Disorders.
- 24S-hydroxycholesterol: cellular effects and variations in brain diseases.
- Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.
- SeSBAT: Single Subject Brain Analysis Toolbox. Application to Huntington's Disease as a Preliminary Study.
- Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics.
- Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.
- Striosomes Mediate Value-Based Learning Vulnerable in Age and a Huntington's Disease Model.
RSS Feed – Literature
HDinHD > RSS Feed – Literature
